Search

everythinglearnresearchcommunity

for

Search:↓

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

U.S. dermatology residents need more education and experience with LGBT patients to improve their cultural competency.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.